News
NIH inventors have developed a new strategy of using Interleukin 24 (IL-24) to target the whole T-helper 17 cells (Th17) lineage and thus achieve improved efficacy in therapy of Th17-relevant autoimmune diseases such as uveitis, multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. The Th17
The Office of Intramural Research, Office of the Director, NIH, invites you to the sixth annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer. The lecture will be held on Friday, December 9, 2011, at 9:30 AM in the Masur Auditorium, Building 10, NIH campus in
In support of his "Startup-America" initiative, President Obama announced a new directive today committing each Federal agency conducting research and development to increasing the successful outcomes of technology transfer and commercialization activities significantly over the next five years
NIH Joins New Consortium for Neglected Tropical Diseases, Malaria & Tuberculosis Product Development
The World Intellectual Property Organization (WIPO), in an unprecedented collaboration with leading pharmaceutical companies, BIO Ventures for Global Health (BVGH) and NIH, has launched WIPO Re:Search, a new consortium where public and private sector organizations share valuable intellectual